Earnings
SBUX
82.78
+1.37%
1.12
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2024
36.18B
36.18B
--
26.44B
9.73B
4.32B
2.52B
--
1.51B
-301.20M
23.30M
565.60M
5.41B
-439.20M
--
--
4.97B
1.21B
3.76B
1.40M
--
--
3.76B
--
3.76B
--
3.76B
3.76B
--
3.76B
1.14B
3.31
3.31
2.28
3.38
FY 2023
35.98B
35.98B
--
26.11B
9.87B
4.00B
2.44B
--
1.36B
-298.40M
-46.30M
539.40M
5.87B
-468.90M
--
--
5.40B
1.28B
4.12B
200.00K
--
--
4.12B
--
4.12B
--
4.12B
4.12B
--
4.12B
1.15B
3.58
3.58
2.12
3.60
FY 2022
32.25B
32.25B
--
23.86B
8.39B
3.77B
2.03B
--
1.45B
-234.10M
80.30M
441.50M
4.62B
-385.90M
--
--
4.23B
948.50M
3.28B
1.80M
--
--
3.28B
--
3.28B
--
3.28B
3.28B
--
3.28B
1.16B
2.83
2.83
1.96
2.92
FY 2021
29.06B
29.06B
--
20.63B
8.44B
2.70B
1.93B
--
1.44B
-385.30M
-649.70M
359.50M
5.74B
-379.70M
--
--
5.36B
1.16B
4.20B
1.00M
--
--
4.20B
--
4.20B
--
4.20B
4.20B
--
4.20B
1.19B
3.54
3.54
1.80
3.15
FY 2020
23.52B
23.52B
--
18.40B
5.12B
3.56B
1.68B
--
1.43B
-322.50M
338.30M
430.30M
1.56B
-397.30M
--
--
1.16B
239.70M
924.70M
-3.60M
--
--
928.30M
--
928.30M
--
928.30M
928.30M
--
928.30M
1.18B
0.79
0.79
1.64
1.08

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.